SAR425899's Dose-Response, Glycemic Control, and Safety Profile to be Determined in Type 2 Diabetes Patients
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Abstract
SAR425899's dose-response, glycemic control, body weight effects, and safety are slated for assessment in a clinical trial involving Type 2 Diabetes patients.